Current strategies for retarding progression of renal disease

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
H S Mackenzie, Barry M Brenner

Abstract

Physiological insights gained in the 1980s into mechanisms of disease progression in experimental chronic nephropathies established the basis for therapeutic interventions to retard the progression of chronic renal disease in humans. In the 1990s, several large-scale clinical trials have confirmed the renoprotective effects of angiotensin-converting enzyme inhibitors in diabetic and nondiabetic nephropathies. Other studies have afforded strong support for the efficacy of dietary protein restriction in certain settings and underscored the importance of blood pressure control in proteinuric individuals. These interventions form the core of current strategies designed to preserve kidney function in patients with chronic renal disease.

Citations

Apr 16, 2013·European Journal of Endocrinology·Akihiro TsudaEiji Ishimura
Sep 12, 2000·Current Hypertension Reports·P S Mehler, R W Schrier
Aug 2, 2002·Expert Opinion on Pharmacotherapy·Alberto VerrottiFrancesco Chiarelli
Jan 5, 2002·Expert Opinion on Investigational Drugs·M Burnier
Apr 2, 2003·Expert Opinion on Pharmacotherapy·Alberto VerrottiFrancesco Chiarelli
Oct 9, 2003·Kidney International·Balakuntalam S Kasinath
Apr 29, 1998·Kidney International·Y ItoR Goldschmeding
Jun 24, 2010·Archives of Gerontology and Geriatrics·Massimo MottaGiovanni Pennisi
Jan 18, 2006·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Hassan YounesJean-Claude Alphonse
Apr 22, 2003·Seminars in Nephrology·Thomas H Hostetter
Oct 11, 2001·Journal of Hypertension·R MarinUNKNOWN Investigators of the ESPIRAL Study. Efecto del tratamiento antihipertensivo Sobre la Progresión de la Insuficiencia RenAL en
Sep 29, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·P L GiudiceP Cochat
Jun 29, 2000·Journal of Hypertension·T T Rosa, P Palatini
Mar 16, 2001·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·D S Bell
Apr 18, 2003·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Cristina M Bouissou SoaresGilce R Oliveira
Feb 3, 2005·Biological & Pharmaceutical Bulletin·Takeyuki YatsuOsamu Inagaki
Jun 18, 2002·The Medical Journal of Australia·Jiqiong YouKathy Eagar
Mar 10, 2001·The Journal of Nutrition·J S SternA T Borchers
Sep 1, 1999·Social Science & Medicine·M TrisoliniW Bicknell
Feb 22, 2001·Journal of the American Society of Nephrology : JASN·Krzysztof StrojekEberhard Ritz
May 8, 1999·Journal of the American Society of Nephrology : JASN·A H Wilkinson, D J Cohen
Mar 3, 2005·European Journal of Pharmacology·Takeyuki YatsuAkihiro Tanaka
Apr 9, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H YounesC Rémésy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.